Keyphrases
Ventricular Assist Device
80%
Cardiac Therapy
63%
Improved Outcomes
63%
Pediatric Heart Transplant
45%
Heart Failure
40%
Heart Transplantation
35%
Pediatric Ventricular Assist Device
30%
Heart Transplant Recipients
25%
Older Adults
20%
Heart Disease
20%
Autoimmune Enteropathy
20%
Ultra-high Frequency
20%
PHOX2B
20%
Embryonic Mortality
20%
Pediatric Circulatory Support
20%
Transplantation Failure
20%
Single Ventricle Palliation
20%
Muscular Dystrophy
20%
Registry Analysis
20%
Nitric Oxide Detection
20%
Cardiac Phenotype
20%
Cardiac Magnetic Resonance Imaging (cMRI)
20%
Prognostic Tool
20%
Echocardiography
20%
Fontan Patients
20%
Cardiac Changes
20%
Fluorescein
20%
Alemtuzumab
20%
Aqueous Solution
20%
Pediatric Cancer Survivors
20%
Copper(II)
20%
Abatacept
20%
Nitric Oxide
20%
Long-term Survival
20%
Society of Thoracic Surgeons
20%
Pedimacs
20%
Paracorporeal
20%
Learning Networks
20%
Device Development
20%
Pediatric Device
20%
Collaborative Learning
20%
Extracellular Volume
16%
Single Ventricle
16%
Conditional Survival
15%
Mortality Factors
15%
Congenital Heart Disease
15%
Preimplantation
13%
Pediatric
13%
Ventricular Assist Device Therapy
12%
Pediatric Patients
11%
Medicine and Dentistry
Ventricular Assist Device
100%
Pediatrics
97%
Heart Transplantation
43%
Congestive Heart Failure
35%
Heart Graft
30%
Heart Single Ventricle
26%
Echocardiography
23%
Symptomatic Treatment
23%
Embryo Death
20%
Muscular Dystrophy
20%
Autonomic Innervation
20%
Alemtuzumab
20%
Abatacept
20%
Pediatric Cancer
20%
Cardiac Magnetic Resonance Imaging
20%
Enteropathy
20%
Brain Natriuretic Peptide
20%
Long Term Survival
20%
Surgeon
20%
Collaborative Learning
20%
Heart Disease
15%
Persistent Truncus Arteriosus
15%
Assisted Circulation
13%
Transplantation
13%
Patient Referral
12%
Pediatrics Patient
11%
Heart Ventricle Contractility
10%
Edema
10%
Embryo Development
10%
Innervation
10%
Biological Marker
10%
Heart Rhythm
10%
Congenital Heart Defect
10%
Cardiac Dysrhythmia
10%
Sudden Death
10%
Anthracycline
10%
Rhythm
10%
Heart Development
10%
Cancer
10%
Graft Failure
10%
Cardiac Allograft Vasculopathy
10%
Apoplexy
9%
Device Therapy
7%
Thymectomy
6%
Adverse Event
6%
Interleukin 1 Receptor Like 1 Protein
6%
Patient Selection
6%
Disease Severity
6%
Disease Course
6%
Immune Dysregulation
6%
